|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Accounts receivable, related party | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Contract assets, related party | ||||||||||||||||||||
| Due from related party | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Capital work-in-progress | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other receivable, related party | ||||||||||||||||||||
| Right of use asset | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts payable, related party | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Related party advances and accruals | ||||||||||||||||||||
| Short-term advances | ||||||||||||||||||||
| Short Term Loan | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Accounts receivable financing facility | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Operating lease liability, current portion | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Loan payable | ||||||||||||||||||||
| Operating lease liability,net of current portion | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Series Quantum Preferred Stock | ||||||||||||||||||||
| Total preferred stock | ||||||||||||||||||||
| Common stock, par value $0.0001, 300,000,000 shares authorized 96,291,416 and 88,254,216 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common shares | ||||||||||||||||||||
| Common stock to be issued (500,000 and 1,500,000 shares as of June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income/(loss) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
